Pharmacy Formulas
A periodical scientific publication, the journal " Formulas of Pharmacy "(hereinafter-the publication), for publishing the main scientific results of dissertations for the degree of candidate of Sciences, for the degree of doctor of Sciences; presents high-quality, peer-reviewed research and interactive clinical content.
Our journal is focused on clinical pharmacologists, specialists of expert organizations, workers centers preclinical and clinical trials of medicinal products; employees of regulatory and Supervisory organizations and institutions in the field of pharmaceutical industry and Russian Ministry of health; researchers, medical and pharmaceutical workers of the organisations and institutions of the Ministry of health; experts of the scientific organizations of RAS and other researchers in the field of environmental security.
The topics of published materials are limited to two branches of science - medical and biological - and they correspond to groups of scientific specialties (03.02.00 General biology, 14.03.00 Biomedical sciences, 14.04.00 Pharmaceutical sciences) in accordance with the order of the Ministry of Education of the Russian Federation dated October 23, 2017 No. 1027 "On the approval of the nomenclature of scientific specialties for which science degrees are awarded" and by order of the Ministry of Education and Science of the Russian Federation of December 12, 2016 No. 1586 (revised March 27, 2018) "On the approval of the rules for forming the list of peer-reviewed scientific publications."
The publication complies with modern rules and requirements of domestic and foreign legislation for peer-reviewed scientific publications.
Journal strategy
When preparing each issue, members of the editorial Board intend to take into account modern requirements for the order of qualified review, information openness and bibliometric indicators in assessing the publication activity of authors, along with other factors of the journal.
To this end, the editorial team uses rigorous: editorial, expert, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance; policies and practices that ensure that authors disclose all relevant financial associations and that such associations do not in any way affect the content published by the journal.
When developing the strategy and layout of the publication, we studied and analyzed the professional materials available to us from information resources of publishers and owners of bibliographic and abstract databases-leaders of international citation systems for relevant branches of science and groups of scientific specialties.
In the course of this work, three groups of scientific specialties were identified, which, in our opinion, made it possible to create a publication's rubricator and determine its name: "Pharmacy Formulas". At the same time, we took into account the definition of pharmacy as the entire life cycle of medicines, including the creation, preclinical and clinical research, production technology, organization of pharmaceutical business, as well as issues of control and analytical research, food and environmental safety. In turn, the word "formulas" means directions, trends, trends in the development of scientific and practical areas that make up pharmacy.
We believe that through our efforts, the journal will keep healthcare and pharmaceutical industry professionals at the forefront of medical and pharmaceutical knowledge, help them deepen their understanding of new areas of interest, and provide valuable insights into scientific and practical medical and pharmaceutical activities.
Authors and readers
To present the results of high-quality scientific research to the reader, we are ready to be responsible for preparing the manuscript to meet the requirements of the journal, quality review of manuscripts , preparing the article for publication, providing opportunities and scientific communications of the founders of the publication to promote the article.
The journal's website meets all the requirements of the international bibliographic database. Full electronic document flow for authors, reviewers, scientific and literary editors is carried out on our own platform.
To promote the article, authors will be able to use the personal website of the publication; assignment of the DOI identifier of the author's manuscript immediately after uploading to the site; unique author ID ORCID; professional social networks Google Scholar, ResearchGate; repositories; open electronic archives; bibliography management system; social media; registration of the scientist as a reviewer; assistance in preparing the use of media (materials for press releases, interviews).
The publishing house of the journal has direct channels for transmitting information to the RSCI and international databases: Scopus, Web of Science, PubMed, CNKI.
When developing all the tasks facing the members of the editorial Board and editorial Board of the journal "Formulas of Pharmacy", we share a common goal: to promote and actively participate in scientific communications on the declared groups of scientific specialties in the biomedical field and pharmacy, from the idea to the release of medicines to the consumer market and management of their waste and metabolites.
Favorite articles
Approaches to training and supply of qualified personnel for radiation medicine facilities
Vol 3, No 1S (2021): Supplement
Chaga and its bioactive complexes: history and perspectives
Vol 2, No 2 (2020)
Moses Efimovich Bergolts: first rector of the revived institute
Vol 2, No 1 (2020)
Rabbit models of ischemic stroke in biomedical research
Vol 1, No 1 (2019)
Current Issue
Vol 7, No 1 (2025)
- Year: 2025
- Articles: 5
- URL: https://journals.eco-vector.com/PharmForm/issue/view/10240
- DOI: https://doi.org/10.17816/phf_71
Full Issue
Pharmaceutical Sciences
Aspects of primary chaga raw material sorting (Inonotus obliquus f. sterilis)
Abstract
In this study, we investigated five non-homogenized chaga raw material samples collected from different regions of the Pskov Region (Russia) and one homogenized sample (in powder form) from the Republic of Serbia. Macroscopic analysis of the four raw material samples allowed for clear differentiation of the crustal zone, medullary region, and mycelial pulp. Micromorphological analysis of all six raw material samples correlated with the aforementioned macroscopic differentiation of the chaga outgrowths and allowed for the identification of diagnostically significant microstructures. For raw material obtained from the crustal zone, brownish-stained hyphal clusters of prosenchymatous texture are diagnostically significant. For raw material from the medullary region of the outgrowth, a more open arrangement of hyphae and the presence of pleurocetes are characteristic. The results of the morphometric analysis allowed for the expansion of the diagnosis of I. obliquus f. sterilis. It was shown that for the intake of aqueous extracts of the fungus for prophylactic purposes, preliminary sorting of raw material parts is not necessary, since different fractions are characterized by different contents of extractable biologically active substances (crust – betulinic acid predominates, medullary region of the outgrowths – β-glucans and melanins, mycelial pulp – inotodiol). For pharmaceutical productions requiring alcohol extraction and subsequent purification of products, on the contrary, it is recommended to carry out preliminary sorting and preparation before drying the raw material. Furthermore, the elemental composition of the chaga raw material samples was determined by X-ray spectral microanalysis based on comparative analysis using the modern analytical method of scanning electron microscopy using a KYKY-EM8000F STD FEG SEM microscope (China) under high vacuum conditions. To assess the elemental composition of the samples, an energy-dispersive microanalysis system (AZtec, Oxford Instruments) was used. Before analysis, the sample was coated with a thin conductive layer of carbon (13 nm) using a Nano-Structured Coating Co vacuum sputtering system (Iran). Thus, the goal of this work – morphometric analysis of various parts of fungal chaga raw material with the assessment of the possibilities of its primary sorting depending on the purposes of further use – was achieved, and the results of the study allowed us to propose aspects of differentiation of chaga raw material during its primary sorting for further use in pharmaceuticals and the production of biologically active additives.



Biomedical Sciences
Cancer Care for Lymphoid Leukemias (C91) in Russia: An Epidemiological and Survival Analysis (A Clinico-Population Study). Part I
Abstract
Analysis of lymphoid leukemia incidence in various regions of the world allows for the identification of significant trends and differences, which can be useful for further research and the development of measures for the prevention and treatment of these diseases. According to the International Classification of Diseases (ICD-10), lymphoid leukemias (LL) are classified under category C91, with subcategories 0, 1-9. Chronic lymphocytic leukemia (CLL) – subcategory C91.1 – accounts for the majority of patients in this category, representing approximately 70% of all LL cases, while acute lymphoblastic leukemia (ALL) – subcategory C91.0 – accounts for approximately 25%. Lymphoid leukemias are cancers of the hematopoietic system. The disease develops in the bone marrow, where blood cells are normally renewed in a balanced manner, but when the formation of healthy cells is disrupted, a vast number of immature white blood cells are produced, leading to anemia. Immature lympholeukemic cells enter the bloodstream and lymphatic system, affecting the entire body. Therefore, ALL and CLL are considered systemic malignant diseases. The aim of the study is to investigate the characteristics of LL prevalence among different age groups of the population, the nature of annual mortality rates, and the dynamics of observed and relative one-year and five-year survival rates of LL patients, considering the patients’ sex, histological structure, and place of residence. The conducted study confirmed an increase in the incidence of LL (C91) in the Russian population in absolute numbers and “crude” rates by 6% and 5%, respectively, which mainly increased due to the ongoing aging process of the population. The growth of the standardized incidence rate of LL (C91) over 11 years in the country amounted to 0.69%. Over four five-year observation periods, a significant decrease in the mortality rate of LL (C91) patients in the first year of observation from 21.4% to 16.6%, or 22.43%, and in the fifth year of observation over three periods by 19.61% was established.



Cancer Care for Leukemias in Russia: Analysis of Prevalence, Mortality, and Survival of Patients with Myeloid (C92), Monocytic (C93), and Other Leukemias (C94-95). Part II
Abstract
This work represents the second part of a study dedicated to investigating leukemias in Russia. The focus is on the prevalence, dynamics of histological structure, and annual mortality of myeloid (C92), monocytic (C93), and other leukemias (C94-95), as well as the assessment of patient survival. The analysis confirmed the relatively low prevalence of these diseases and the limited progress in improving treatment outcomes over the past two decades. An important aspect is the use of data from the Population-Based Cancer Registry (PBCR) of the Northwestern Federal District (NWFD), which contains information on over 1.6 million observations, including 28.7 thousand cases of leukemia. This allows us to overcome the limitations associated with the predominance of foreign and clinical data in Russian scientific literature. In addition, the results of the survival analysis of patients with lymphoblastic leukemia (C91), conducted taking into account age, sex, and region of residence (a continuation of the first part of the study), are presented. The aim of the study is to investigate the prevalence of myeloid (C92), monocytic (C93), and other leukemias (C94-95) among the population in Russia, the dynamics of detailed histological structure, and annual mortality. To calculate the survival of patients. The conducted study, with an analysis of the prevalence of myeloid and monocytic leukemias, confirmed the rarity of this pathology and the modest success in the treatment of patients. Over the past two decades, patient mortality has remained virtually unchanged.



Biological sciences
Review and assessment of the significance of scientific works by I.V. Zmitrovich, devoted to the processes of biological development and eukaryote megataxonomy
Abstract
The present review provides a detailed bibliographic analysis of scientific works, including little-known ones, by I.V. Zmitrovich, devoted to the processes of biological development and taxonomy of eukaryotes. As the study of the bibliographic heritage of I.V. Zmitrovich has shown, important issues of theoretical biology raised in his works were morphogenesis, adaptogenesis, and eukaryote megataxonomy. First of all, by the specificity of affiliation, I.V. Zmitrovich was interested in fungi – osmoheterotrophic organisms with a chitinous cell wall, an open growth system, resembling plants and for a long time attributed to this kingdom. However, consideration of the tendencies of the development of multicellularity and modular theory expanded the realm of interests of this researcher, being extended to the evolution of the vegetative body of plant organism, including higher plants with different types of cells and tissue differentiation. The purpose of this review was to study and acquaint our readers with the numerous scientific works by I.V. Zmitrovich devoted to the morphogenesis and taxonomy of eukaryotes of the last thirty years, many of which, in our opinion, were undeservedly lost in the intensifying flow of scientific and technical information of recent years.



Heritage
A lesser-known biography of Professor Yu.D. Zilber (1926–2003)
Abstract
This essay, bearing a documentary and biographical nature, is the result of a documented and scientific understanding of the scientific and pedagogical activities of Professor Yuri Davidovich Zilber, Doctor of Medical Sciences. The stylistic and linguistic structure of the essay fully corresponds to the authors’ goal: to create a concise and laconic picture of the labor, scientific, and pedagogical activities of Professor Yu.D. Zilber. We faced the challenge of gathering disparate documentary information and materials, as well as the recollections of relatives and colleagues, which helped to reveal the character and contribution of Yuri Davidovich to medical and biological sciences as a significant scientist and educator. In our opinion, we succeeded in researching and describing the key stages in the formation of Yu.D. Zilber as a physician and scientist: the years of study, the difficult trials during the Great Patriotic War, and his fruitful scientific and pedagogical activities. We utilized surviving archival documents and scientific publications from the St. Petersburg State Chemical Pharmaceutical University, the Military Medical Museum, and the Zilber family archive. The authors hope that the results of this research will be of interest to students and teachers of our university studying the history of medicine and pharmacy, as well as to a wide range of readers interested in the fates of significant and outstanding scientists.


